Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 673.50
Bid: 674.50
Ask: 675.00
Change: -2.00 (-0.30%)
Spread: 0.50 (0.074%)
Open: 676.00
High: 676.00
Low: 669.50
Prev. Close: 675.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tate & Lyle Group Pension Scheme agrees £347 million partial pensioner buy-in

7 Dec 2012 07:00

null

7 December 2012 - Tate & Lyle PLC

Tate & Lyle Group Pension Scheme agrees £347 million partial pensioner buy-in

Tate & Lyle PLC ("Tate & Lyle") announces that the Trustee of the Tate & Lyle Group Pension Scheme, Tate & Lyle's principal UK defined benefit scheme ("the Group Scheme") has agreed a £347 million partial pensioner buy-in of approximately 43% of total pensioner liabilities with Legal & General plc ("L&G"), which effectively hedges these liabilities in full.

Tim Lodge, Tate & Lyle's Chief Financial Officer, said "Tate & Lyle is committed to meeting our pension commitments to existing and former colleagues. We are delighted the Group Scheme Trustee has secured this agreement with L&G, well known as a high-quality long-standing annuity provider. This transaction is an important step in our strategy to work with our schemes' trustees and fiduciaries to reduce pension risk on a phased basis over time."

The buy-in effectively covers around 43% of the Group Scheme's total pensioner liabilities and represents approximately 30% of the Scheme's total liabilities based on the 'Technical Provisions' assumptions agreed with the Trustee at the last triennial valuation updated for current market conditions.

The buy-in involves the purchase of a bulk annuity policy under which L&G will pay to the Trustee amounts equivalent to the benefits payable to three out of every seven of the Group Scheme's pensioner members ("the Buy-In Members"). The premium for the annuity policy is £347 million and will be paid by the Trustee in a combination of assets and cash from the Group Scheme. It is anticipated that there will be no material impact on the Group's cash flows or adjusted (note 1) earnings as a result of the partial buy-in.

The pension liabilities for the Buy-In Members remain with the Group Scheme, and the matching L&G annuity policy will be held within the Group Scheme as an investment of the Trustee, so the benefits of Group Scheme members are unaffected by this transaction and members will not see any changes in the way their pensions are paid.

Note 1 adjusted earnings exclude exceptional items, post-retirement benefit interest and amortisation of intangible assets acquired through business combinations

END

For more information contact Tate & Lyle PLC:

Mathew Wootton, Group VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7500 100 320

or

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

Note to editors

As at 30 September 2012, Tate & Lyle had recognised a total gross retirement benefit asset of £1,375 million and total gross liabilities of £1,592 million under the IFRS accounting rules, of which £932 million and £828 million related to the Group Scheme.

Copyright Business Wire 2012

Date   Source Headline
8th Nov 20237:00 amRNSDirectorate Change
23rd Oct 202310:30 amRNSHolding(s) in Company
16th Oct 202310:30 amRNSHolding(s) in Company
13th Oct 202310:30 amRNSHolding(s) in Company
12th Oct 202311:00 amRNSHolding(s) in Company
2nd Oct 202310:23 amRNSDirector Declaration
1st Sep 202311:00 amRNSTotal Voting Rights
25th Aug 20233:45 pmRNSHolding(s) in Company
17th Aug 20234:30 pmRNSHolding(s) in Company
15th Aug 20234:30 pmRNSHolding(s) in Company
10th Aug 20234:00 pmRNSHolding(s) in Company
7th Aug 202312:15 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:45 pmRNSDirector/PDMR Shareholding
2nd Aug 202311:30 amRNSHolding(s) in Company
1st Aug 202311:15 amRNSTotal Voting Rights
28th Jul 202312:00 pmRNSDirector/PDMR Shareholding
27th Jul 20231:15 pmRNSResult of AGM
27th Jul 20239:30 amRNSHolding(s) in Company
26th Jul 202311:30 amRNSHolding(s) in Company
25th Jul 202311:30 amRNSHolding(s) in Company
24th Jul 202312:30 pmRNSHolding(s) in Company
18th Jul 202312:30 pmRNSHolding(s) in Company
4th Jul 20233:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:10 pmRNSBlock listing Interim Review
3rd Jul 20232:00 pmRNSTotal Voting Rights
3rd Jul 20237:02 amRNSDirectorate Change
29th Jun 20233:30 pmRNSHolding(s) in Company
28th Jun 20232:00 pmRNSHolding(s) in Company
7th Jun 20232:30 pmRNSDirector/PDMR Shareholding
6th Jun 202312:30 pmRNSAnnual Financial Report and Notice of AGM 2023
1st Jun 202312:00 pmRNSTotal Voting Rights
25th May 20237:00 amRNSFinal Results
18th May 20239:30 amRNSDirector Declaration
2nd May 20232:30 pmRNSTotal Voting Rights
4th Apr 202311:00 amRNSOperating Segment Restatement
3rd Apr 20234:15 pmRNSTotal Voting Rights
8th Mar 20232:30 pmRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNSCapital Markets Event
26th Jan 20237:00 amRNSTrading Statement
6th Jan 20232:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20233:17 pmRNSBlock listing Interim Review
8th Dec 20221:00 pmRNSDirector/PDMR Shareholding
30th Nov 20222:00 pmRNSHolding(s) in Company
10th Nov 20227:00 amRNSHalf-year Report
1st Nov 20223:15 pmRNSTotal Voting Rights
4th Oct 20228:25 amRNSCancellation of Preference Share Listing
3rd Oct 20222:45 pmRNSPref. share reduction effective & timetable update
29th Sep 20221:00 pmRNSTimetable update re. cancellation of pref. shares
14th Sep 202212:15 pmRNSHolding(s) in Company
13th Sep 20223:00 pmRNSCourt approval of cancellation of Pref. shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.